Enterovirus 71 infection in children with hand, foot, and mouth disease in Shanghai, China: epidemiology, clinical feature and diagnosis by Ying Wang et al.
Wang et al. Virology Journal  (2015) 12:83 
DOI 10.1186/s12985-015-0308-2RESEARCH Open AccessEnterovirus 71 infection in children with
hand, foot, and mouth disease in Shanghai,
China: epidemiology, clinical feature and
diagnosis
Ying Wang1,3†, Gang Zou3†, Aimei Xia2†, Xiangshi Wang2, Jiehao Cai2, Qianqian Gao1,3, Shilin Yuan3, Guimei He1,
Shuyi Zhang1, Mei Zeng2* and Ralf Altmeyer3*Abstract
Background: In 2012 a large outbreak of hand, foot, and mouth disease (HFMD) widely spread over China, causing
more than 2 million cases and 567 deaths. Our purpose was to characterize the major pathogens responsible for
the 2012 HFMD outbreak and analyze the genetic characterization of the enterovirus 71 (EV71) strains in Shanghai;
also, to analyze the dynamic patterns of neutralizing antibody (NAb) against EV71 and evaluate the diagnostic value
of several methods for clinical detection of EV71.
Methods: Clinical samples including stool, serum and CSF were collected from 396 enrolled HFMD inpatients during the
peak seasons in 2012. We analyzed the molecular epidemiology, clinical feature, and diagnostic tests of EV71 infection.
Results: EV71 was responsible for 60.35 % of HFMD inpatients and 88.46 % of severe cases. The circulating EV71 strains
belonged to subgenogroup C4a. The nucleotide sequences of VP1 between severe cases and uncomplicated cases
shared 99.2 ~ 100 % of homology. Among 218 cases with EV71 infection, 211 (96.79 %) serum samples showed NAb
positive against EV71 and NAb titer reached higher level 3 days after disease onset. Of 92 cases with EV71-associated
meningitis or encephalitis, 5 (5.43 %) of 92 had EV71 RNA detected in CSF samples. The blood anti-EV71 IgM assay
showed a sensitivity of 93.30 % and a specificity of 50 %.
Conclusions: EV71 C4a remained the predominant subgenotype circulating in Shanghai. The severity of the EV71
infection is not associated with the virulence determinants in VP1. RT-PCR together with IgM detection can enhance
the early diagnosis of severe EV71-associated HFMD.
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Hand, foot, and mouth disease (HFMD) has been an
emerging highly contagious disease in children in countries
of the Western Pacific Region since the late nineties,
posing a serious public health threat. HFMD is usually
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creativecommons.org/publicdomain/zero/1.0/characterized by fever, ulcerating vesicles in the mouth and
macula or papulovesicular on hands, feet and buttocks
[1–4]. However, a small proportion of the affected
children may develop neurological and cardiopulmonary
complications with high case fatality rates [5, 6]. The
mainland China has been experiencing the persistent
national outbreaks of HFMD since 2008. According to the
data from the national surveillance system of HFMD in
mainland China in 2008–2012, the case-fatality rate of
HFMD is 0.03 % and the case-severity rate is 1.1 % [7].
HFMD is caused by enteroviruses belonging to the species
Enterovirus A (serotypes Coxsackie virus A 2–8, 10, 12,
14, 16 and enterovirus 71, 76 and 89–92), and rarely byicle distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
. The Creative Commons Public Domain Dedication waiver (http://
) applies to the data made available in this article, unless otherwise stated.
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agents [8, 9]. In China, EV71 infection has been associated
with large outbreaks of HFMD and the majority of fatalities.
EV71, first isolated in 1969, is a single, positively-
stranded RNA virus without envelope [10, 11]. The VP1
protein of EV71 contains a number of important
neutralization epitopes and has been extensively used for
molecular typing [12–14]. EV71 can be phylogenetically
classified into 3 main genogroups (A, B and C) and 11
genotypes (A, B1 ~ B5 and C1 ~ C5) based on VP1
sequences [15, 16]. Monitoring the genetic variations of
circulating EV71 strains and the emergence of new types
or recombinants of EV71 in the epidemic regions is
important for vaccine development and drug discovery.
In 2012, 2,198,442 HFMD cases and 567 deaths-
associated with HFMD were reported in mainland
China, with the number of the notifiable cases and the
fatal cases being 33.90 % and 11.39 % higher than those
in 2011, respectively [7]. Meanwhile, the outbreaks of
EV71 infection and HFMD were also reported in Malaysia,
Thailand, and Cambodia in 2012 [17–19]. In this study, we
collected feces, serum and CSF specimens from 396
HFMD inpatients in Shanghai during the 2012 peak
season. Our purpose was to characterize the major patho-
gens responsible for this outbreak and to analyze the
genetic characterization of the EV71 strains. Besides,
we analyzed the dynamic patterns of neutralizing antibody
(NAb) titer against EV71 and evaluated the diagnostic




A total of 396 inpatients with HFMD including 292
(73.7 %) uncomplicated cases and 104 (26.3 %) severe cases
were enrolled into this study from March 28th to July 5th
in 2012, representing 47.2 % of all hospitalized HFMD cases
(778) at the CHFU during the study period. The 104 severe
cases included 94 (92.16 %) aseptic meningitis, 4 (3.85 %)
encephalitis, 3 (2.94 %) encephalomyelitis and 3 (2.94 %)
brain stem encephalitis with neurogenic pulmonary
hemorrhage/edema. Three severe cases with laboratory-
confirmed EV71 infections were fatal with 2 female infants
(both were 7 months) succumbing to cardiopulmonary
failure and 1 female child (5.7 years) succumbing to
central respiratory failure.
Of the 396 patients, the male-to-female ratio was
1.75:1 and the age range was between 3 months and
12.7 years with the median age of 29 months old and
357 (90.15 %) cases <5 years old, of whom, 1- to 2-year-
old children accounted for 127 (32.07 %) cases. Persistent
fever >3 days, vomiting, startle, myoclonus and higher
positive rate of EV71-RNA in stool were significantly
more frequent in severe cases (Table 1).EV71 detection in the stool samples by real-time RT-PCR
EV71 was identified in 239 (60.35 %) cases, CA16 was
identified in 82 (20.71 %) cases, EV71 and CA16 were
co-detected in 3 (0.758 %) uncomplicated cases and
the remaining 72 (18.18 %) cases contained untyped
enteroviruses. Among the 104 severe cases, 92 (88.46 %)
were positive for EV71 while only 149 (51.02 %) positive
for EV71 in 292 uncomplicated cases, revealing that
EV71 was more frequently in severe cases than in uncom-
plicated cases (χ2 = 45.113, p < 0.0001).
EV71 detection in blood samples
The average blood sampling days were 3.4 ± 1.3 days
(range: 1–8 days) after disease onset. Among 218 cases
with EV71 positivity in stool samples, 211 (96.79 %)
were positive for NAb against EV71; meanwhile, among
138 cases with EV71 negativity in stool samples, 31
(22.46 %) were also positive for NAb against EV71. We
analyzed the levels of NAb titers in sera from patients
with EV71-RNA positivity in their stool samples. As
shown in Fig. 1, we found that NAb GMT significantly
increased with the time of disease onset (χ2 = 46.10,
p < 0.0001) and reached the highest level at day 6.
Although NAb GMT decreased at day 7 and day 8
after disease onset, there was no significant difference
in NAb GMT at day 6, day 7 and day 8 after disease
onset (χ2 = 1.912, p = 0.385).
Of 200 serum samples obtained from the patients with
EV71 RNA positive in stool samples and positive NAb
against EV71, 151 (75.5 %) were positive for EV71 RNA
in sera. Serum EV71 RNA was detected positive in 44
(60.27 %) of 73 severe cases and 107 (84.25 %) of 127
uncomplicated cases, respectively (χ2 = 14.41, p = 0.0001).
The NAb GMT was 1122.5 and 1622.6 in 73 severe cases
and 127 uncomplicated cases, respectively (χ2 = 4.084,
p = 0.043), indicating there was no difference in the NAb
titer level between severe cases and uncomplicated cases.
The average serum sampling days after disease onset
was 3.18 ± 1.04 days (range: 1–5 days) in severe cases and
3.9 ± 1.34 days in uncomplicated cases (range: 1–8 days)
(χ2 = 15.90, p < 0.0001), respectively.
Of the enrolled 396 patients, 267 who had both
EV71-RNA detected in stool samples and NAb detected
in serum samples had EV71 IgM tested in whole blood
samples from finger tip. Compared to the EV71 infection
confirmed by both positive EV71-RNA in stool and posi-
tive serum NAb against EV71, blood EV71 IgM showed a
sensitivity of 93.30 % and a specificity of 50 %; the positive
predict value was 79.15 % and the negative predict value
was 78.57 % (Table 2).
Phylogenetic analyses of VP1 gene of EV71
The entire VP1 region of EV71 was amplified using RT-
PCR directly from the clinical serum and CSF specimens
Table 1 Comparison of clinical manifestations between uncomplicated cases and severe cases
All cases Uncomplicated Severe Χ2 P value*
(396) (73.74 %, 292) (26.26 %,104)
Male to female ratio 1.75 (252/144) 1.92 (192/100) 1.36 (60/44) 2.153 0.155
Fever > 3 days 16.41 % (65) 11.64 % (34) 29.81 % (31) 18.441 <0.0001
Oral rash 88.38 % (350) 89.38 %(261) 85.58 % (89) 1.082 0.291
Vomiting 45.45 % (180) 38.70 % (113) 64.42 % (67) 20.468 <0.0001
Headache 2.53 % (10) 2.05 % (6) 3.85 % (4) 1.000 0.298
Startle 57.32 % (227) 46.92 % (137) 86.54 % (90) 49.209 <0.0001
Convulsion 1.26 % (5) 0.68 % (2) 2.88 %(3) 2.976 0.116
Myoclonus 35.10 % (139) 21.92 % (64) 72.12 % (75) 84.826 <0.0001
EV71-RNA positive in stool 242 (61.11 %) 143 (48.97 %) 99 (95.19 %) 68.933 <0.0001
*Chi-squared test was used to evaluate the significant variation of clinical manifestations between uncomplicated cases and severe cases. The p value less than
0.05 was considered to be significant and marked in bold
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mutations selected during serial passage. EV71 RNA was
detected in 5 (5.43 %) of 92 CSF samples obtained from
the severe patients with EV71 RNA positive in the stool
samples. The PCR products of 151 EV71-positive serum
samples and 5 EV71-positive CSF samples could be
sequenced successfully. The EV71 VP1 nucleotide and
amino acid sequence among the 2012 Shanghai strains
showed 99.2 ~ 99.8 % and 98.9 ~ 99.6 % identity,
respectively. Based on the VP1 sequences, the nucleotide
and amino acid homologies between severe cases and
uncomplicated cases were 99.2 ~ 100 % and 98.9 ~ 100 %,
respectively.
A phylogenetic tree was constructed based on VP1
sequences to determine the subgroups and subgenotypes
of EV71 strains. Seventy reference sequences were
obtained from GenBank, including 11 subgenotypes
(A, B1-B5, and C1-C5) and representative strains epidemic
in China since 2007. In addition, another twenty-six VP1
sequences of EV71 from 2008 to 2011 isolated in ShanghaiFig. 1 Neutralizing antibody titers in HFMD inpatients after days of
disease onsetwere also used for alignment analyses. As shown in Fig. 2,
all the Shanghai sequences were classified into the C4a
cluster which was predominant since the 2008 HFMD
outbreak in mainland China. The 2012 Shanghai EV71
strains shared a high degree of nucleotide homology
(98.5 ~ 99.8 %) with 2008 Anhui strain 18.08/AH/
CHN/2008. It should be noted that the nine 2012
Shanghai strains formed a separated subcluster (99 %
bootstrap value) of the C4a clade from the 2011
Shanghai strains fell within the same cluster as the
EV71 strains isolated from Guangdong, Shandong and
Anhui regions in China during 2008–2009, sharing
96.63 ~ 98.88 % nucleotide and 98.32 ~ 99.66 % amino
acid homologies, respectively. The VP1 sequences of
2012 EV71 strains circulating in Shanghai shared
93.94-99.33 % nucleotide and 96.97-98.99 % amino acid
homologies with the 2008–2011 strains.
Discussion
Although multiple genotypes and subgenotype of EV71
are circulating simultaneously or alternatively in other
countries and regions, [20, 21] our study revealed that
EV71 remained the predominant enterovirus causing the
2012 large outbreaks of HFMD and severe central nerves
system (CNS) disease in Shanghai. Combined with our
previous surveillance data, [22, 23] we reason that the
principal strategy of controlling the HFMD outbreak
in Shanghai is to prevent the EV71 circulation in children
through mass EV71 vaccination. In line with previousTable 2 Evaluation of blood EV71 IgM rapid test kit
Blood EV71-IgM
antibody
stool EV71-RNA and serum NAb against EV71
Both positive Both negative Total
Positive 167 44 211
Negative 12 44 56
Total 179 88 267
Fig. 2 (See legend on next page.)
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Fig. 2 Phylogenetic analysis of EV71 from Shanghai, 2012. The phylogenetic tree was based on the alignment of entire VP1 sequences using
Neighbor-Joining method with bootstrap value 1000 pseudoreplicates. Bootstrap values with > 75 replications were shown at the branch nodes.
The scale bar represented the genetic distance of 0.02 nucleotide substitutions per site.▲ indicated EV71 strains from Shanghai, 2011, ● indicated
EV71 strains from Shanghai, 2012. Other strains are obtained from GenBank (listed in Additional file 1)
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vomiting, startle, and myoclonus can be used as the warn-
ing signs for predicting the severe HFMD cases [8, 24].
We noted that the VP1 sequences of EV71 strains
from severe cases were indistinguishable from those
causing uncomplicated symptoms, which is same as
other reports [11, 25, 26]. Besides, the VP1 sequences of
EV71 strains in the serum and CSF specimens collected
from the same patients were identical, suggesting the
individual patient appeared to be infected with a single
genotype of EV71. Phylogenetic analysis suggests that the
constant genetic evolution of the EV71 strains circulating
in Shanghai occurred in the VP1 gene over the year. It
deserves to further explore the effect of the genetic
evolution of VP1 on the antigen change of EV71 [27, 28].
Previous studies have reported that the residue L97 and
domain 215-KQEKD-219 on VP1 protein of EV71 were
associated with neutralizing epitope. We found that these
neutralizing epitopes were unchanged in all the Shanghai
strains, making the development and long-term use of
EV71 vaccine feasible [29, 30].
Neutralization antibody plays an important role in
immunoprotection from viral infection as it can efficiently
bind virus, neutralize virus, and thus prevent the further
progression of disease. It is usually believed that NAb
produces and reaches the peak level during the late
convalescent stage of viral infection. Based on these
theories, IVIG containing NAb against EV71 is rec-
ommended for treating the severe EV71-associated
diseases in many countries including our countries
[21, 31]. Clinical observational study from Malaysia
showed early IVIG therapy in severe EV71-associated
HFMD patients might have a beneficial effect on halting
disease progression and improve the outcomes [32]. Also,
a mice model study showed that plasma containing high
titer EV71-sepcific IVIG products can confer protection
against lethal EV71 challenge [33]. However, we observed
that serum NAb against EV71 has produced in over
95 % of EV71-infected HFMD patients when the
HFMD-related symptoms appear and reaches the high
level within 3–6 days after disease onset. In clinical
setting, severe cases were admitted to hospital usually
on day 3 after disease onset when NAb has already
reached the high level. Therefore, our data suggest that if
IVIG has any benefit in the treatment of HFMD, it is likely
not due to the direct antivrial effect of EV71 neutralizing
Abs. An immunomodulatory effect of IVIG has been
proposed by In vitro data [34].We detected 5 EV71 strains in 92 CSF samples using
RT-PCR method and obtained the sequences of EV71.
However, EV71 could not be isolated from CSF samples
after 5 passages in RD cells. Obviously, CSF samples are
not suitable to be used as the prior clinical samples for
the diagnosis of EV71-associated CNS infections. Other
studies reported the difficulty in isolating EV71 from
CSF due to low amount of viral load, sensitivity of PCR,
and intrathecal antibody in CSF [5, 22, 35, 36]. Real-time
RT-PCR and viral isolation are considered as the standard
methods in clinical diagnosis of viral infection. Although
real-time RT-PCR has the advantage of high sensitivity
and specificity in the diagnosis of EV71 infection in
clinical samples, it takes 2–3 h to get the result and
requires the expensive equipment in the hospital labora-
tory. Also, virus isolation is time-consuming and insensi-
tive. The fatal HFMD was almost always caused by EV71
infection and the severe disease progress is very fast, thus,
timely and rapid diagnosis of EV71 infection for suspected
severe HFMD is critical for clinical management and
early intervention [37]. Thus, a rapid, sensitive and conveni-
ent bedside diagnostic tool is needed in clinical practice.
Blood EV71-IgM-Colloidal Gold immunochromatographic
assay is easy to perform and provides the result within
15 min. It has high sensitivity and negative predict value
but low specificity and positive predict value, therefore,
EV71-IgM-Colloidal Gold assay as the confirmatory test for
diagnosing EV71 infection was not recommended.
However, given the high sensitivity and convenience,
finger tip blood EV71 IgM test can be used as a rapid
point-of-care screen tool and an essential supplement for
the early diagnosis of EV71 infection to help clinicians
timely recognize severe EV71-associated diseases.
The upcoming EV71 vaccination in China is a promising
strategy to prevent the large outbreak of HFMD. Early
recognition of progressive symptoms and timely diagnosis
of EV71 infection in suspected severe HFMD will help
take appropriate clinical intervention to reduce the fatality
through intensive care. Ongoing surveillance of HFMD
and EV71 infections and evolution of EV71 strains is
necessary for control of HFMD in China and the formula-
tion of EV71 vaccine before and after vaccine available in
the market.
Conclusions
This study revealed that EV71 remained the predominant
enterovirus causing the 2012 large outbreaks of HFMD
and severe CNS disease in Shanghai. We observed the
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fact, serum NAb against EV71 in HFMD patients has
reached higher level 3 days after disease onset. Real-time
RT-PCR together with IgM detection would enhance
the detection of HFMD and thereby should be highly
recommended in clinical therapy. Our findings provide
important epidemiological information of HFMD epidemic
in Shanghai and evaluate the issues regarding the labora-
tory diagnosis of EV71 infection.
Methods
Specimen and data collection
Clinical specimens used in this study were collected
from hospitalized HFMD patients during the 2012 peak
season (March 28th – July 5th) of HFMD in Shanghai at
the Children’s Hospital of Fudan University (CHFU).
The study was approved by the Ethics Committee of the
study hospital. Both stool samples and serum samples
were collected within 24 h after admission and a CSF
sample was collected if a patient was highly suspected to
have central nervous involvement and had a successful
lumbar puncture procedure for the routine CSF diagnostic
tests. A severe case was defined by HFMD accompanied
with at least one of the following complications: aseptic
meningitis, encephalitis, acute flaccid paralysis, pulmonary
edema or hemorrhage, cardiopulmonary collapse. CSF
pleocytosis was defined as a white blood cell count more
than 10 × 106 cells/L in a patient older than 1 month of
age. A total of 263 serum specimens were collected from
292 uncomplicated HFMD patients, and 93 serum
and 92 CSF specimens were collected from 104 severe
HFMD patients. All the samples were stored at −80 °C for
further tests. Clinical data were recorded using case-
report form (CRF) and re-assessed by an infectious disease
specialist.
Detection of EV71 infection in clinical laboratory
EV71 detection in stool specimens was performed using
commercially available pan-enterovirus, EV71, and CA16
diagnostic kit (Da An Gene Co., Ltd, Guangzhou, China)
according to manufacturer’s instructions. Anti-EV71 IgM
was detected in the peripheral finger tip blood sample
using EV71-IgM-Colloidal Gold immunochromatographic
assay (Beijing Wantai Biological Pharmacy Enterprise Co.,
Ltd., China).
RT-PCR detection, virus isolation, and neutralization assay
Viral RNA was extracted from serum and CSF speci-
mens using a QIAamp Viral RNA Mini Kit (Qiagen,
Hilden, Germany). Direct RT-PCR was performed
using SuperScript III One-Step System with Platinum
Taq High Fidelity (Invitrogen, USA) with primer tar-
geting EV71 VP1 gene (2372 F: 5’-GCAGCCCAAAA
GAACTTCAC-3’, and 3454R: 5’-AAGTCGCGAGAGCTGTCTTC-3’) [1]. The resulting 1083-bp PCR product
was analyzed on a 1 % agarose gel, and then purified
using TIANgel Midi Purification Kit (TIANGEN,
China) for sequencing. Of 92 CSF samples, 5 were
positive using direct RT-PCR. However, virus isolation
for 92 CSF samples using the strategy described in
previous study was unsuccessful [38]. Neutralization
assay was performed using the method described in
previous study [39].Sequencing of EV71 strains and phylogenetic analyses
The gel purified PCR products were bi-directionally
sequenced using an ABI 3730xl automatic DNA analyzer.
Alignment of the entire VP1 nucleotide sequences
(891 bp) of the EV71 strain was performed using Clustal
W program. Phylogenetic tree was constructed in
MEGA 5.2 (Molecular Evolutionary Genetics Analysis
software; Tamura, Dudley, Nei, and Kumar 2012) using
Neighbor-joining method in Kimura two-parameter model,
accompanied by bootstrap analyses with 1000 repli-
cates. The entire VP1 nucleotide sequences of the nine
Shanghai EV71 strains and reference sequences obtained
from GenBank were listed with accession numbers in
Additional file 1.Statistical analyses
The data were analyzed using Microsoft Excel 2010,
SPSS software version 19.0 and GraphPad Prism
V5.01 software. The percentage of clinical data was
analyzed using the chi-square test. NAb titers were
log-transformed to geometric mean titers (GMT) for
statistical analysis. GMT and the mean sampling days
were analyzed using Kruskal Wallis test. The p value less
than 0.05 was considered to be statistically significant.Additional file
Additional file 1: The list of EV71 strains used for phylogenetic
analysis in this study.Competing interests
All authors declare that they have no competing interests.
Authors’ contributions
AX, XW, JC carried out the specimen collection, clinical data record and
real-time RT-PCR. YW, QG, SY carried out the molecular genetic studies,
participated in the sequence alignment. YW participated in the neutralization
and performed the statistical analysis. YW, MZ and GZ drafted the manuscript.
MZ, RA, GZ, GH and SZ participated in the design of the study. All authors read
and approved the final manuscript.
Acknowledgement
This study was supported by Pasteur International Network Association. We
thank Dr. Chiyu Zhang from Pathogen Diagnostic Center, Institut Pasteur of
Shanghai for thoughtful comments and review of the manuscript.
Wang et al. Virology Journal  (2015) 12:83 Page 7 of 7Author details
1Institute of Molecular Ecology and Evolution, SKLEC & IECR, East China
Normal University, Shanghai 200062, China. 2Department of Infectious
Diseases, Children’s Hospital of Fudan University, Shanghai 201102, China.
3Unit of Anti-infective Research, Key Laboratory of Molecular Virology &
Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences,
Shanghai 200031, China.
Received: 2 March 2015 Accepted: 8 May 2015
References
1. Zhang Y, Tan XJ, Wang HY, Yan DM, Zhu SL, Wang DY, et al. An outbreak of
hand, foot, and mouth disease associated with subgenotype C4 of human
enterovirus 71 in Shandong, China. J Clin Virol. 2009;44:262–7.
2. Chong CY, Chan KP, Shah VA, Ng WY, Lau G, Teo TE, et al. Hand, foot and
mouth disease in Singapore: a comparison of fatal and non-fatal cases.
Acta Paediatr. 2003;92:1163–9.
3. Ho M, Chen ER, Hsu KH, Twu SJ, Chen KT, Tsai SF, et al. An epidemic of
enterovirus 71 infection in Taiwan. Taiwan Enterovirus Epidemic Working
Group. N Engl J Med. 1999;341:929–35.
4. Sabanathan S, Tanle V, Thwaites L, Wills B, Qui PT, RogiervanDoorn H.
Enterovirus 71 related severe hand, foot and mouth disease outbreaks in
South-East Asia: current situation and ongoing challenges. J Epidemiol
Community Health. 2014;68:500–2.
5. Chang LY, Lin TY, Hsu KH, Huang YC, Lin KL, Hsueh C, et al. Clinical features
and risk factors of pulmonary oedema after enterovirus-71-related hand,
foot, and mouth disease. Lancet. 1999;354:1682–6.
6. Chan LG, Parashar UD, Lye MS, Ong FG, Zaki SR, Alexander JP, et al. Deaths
of children during an outbreak of hand, foot, and mouth disease in sarawak,
malaysia: clinical and pathological characteristics of the disease. For the
Outbreak Study Group. Clin Infect Dis. 2000;31:678–83.
7. Xing W, Liao Q, Viboud C, Zhang J, Sun J, Wu JT, et al. Hand, foot, and
mouth disease in China, 2008–12: an epidemiological study. Lancet Infect
Dis. 2014;14:308–18.
8. Liu W, Wu S, Xiong Y, Li T, Wen Z, Yan M, et al. Co-Circulation and Genomic
Recombination of Coxsackievirus A16 and Enterovirus 71 during a Large
Outbreak of Hand, Foot, and Mouth Disease in Central China. PLoS One.
2014;9, e96051.
9. Yip CC, Lau SK, Zhou B, Zhang MX, Tsoi HW, Chan KH, et al. Emergence of
enterovirus 71 “double-recombinant” strains belonging to a novel genotype
D originating from southern China: first evidence for combination of
intratypic and intertypic recombination events in EV71. Arch Virol.
2010;155:1413–24.
10. Schmidt RC, Maassab HF. Local immunity to influenza virus in chicken
tracheal organ cultures. J Infect Dis. 1974;129:637–43.
11. Zhang Y, Zhu Z, Yang W, Ren J, Tan X, Wang Y, et al. An emerging
recombinant human enterovirus 71 responsible for the 2008 outbreak of
hand foot and mouth disease in Fuyang city of China. Virol J. 2010;7:94.
12. Oberste MS, Maher K, Kilpatrick DR, Flemister MR, Brown BA, Pallansch MA.
Typing of human enteroviruses by partial sequencing of VP1. J Clin
Microbiol. 1999;37:1288–93.
13. Oberste MS, Maher K, Kilpatrick DR, Pallansch MA. Molecular evolution of
the human enteroviruses: correlation of serotype with VP1 sequence and
application to picornavirus classification. J Virol. 1999;73:1941–8.
14. Caro V, Guillot S, Delpeyroux F, Crainic R. Molecular strategy for ‘serotyping’
of human enteroviruses. J Gen Virol. 2001;82:79–91.
15. Brown BA, Oberste MS, Alexander Jr JP, Kennett ML, Pallansch MA.
Molecular epidemiology and evolution of enterovirus 71 strains isolated
from 1970 to 1998. J Virol. 1999;73:9969–75.
16. Akhmadishina LV, Eremeeva TP, Trotsenko OE, Ivanova OE, Mikhailov MI,
Lukashev AN. Seroepidemiology and molecular epidemiology of enterovirus
71 in Russia. PLoS One. 2014;9, e97404.
17. Sham NM, Krishnarajah I, Ibrahim NA, Lye MS. Temporal and spatial
mapping of hand, foot and mouth disease in Sarawak, Malaysia. Geospat
Health. 2014;8:503–7.
18. Puenpa J, Mauleekoonphairoj J, Linsuwanon P, Suwannakarn K,
Chieochansin T, Korkong S, et al. Prevalence and Characterization of
Enterovirus Infections among Pediatric Patients with Hand Foot Mouth
Disease, Herpangina and Influenza Like Illness in Thailand, 2012. PLoS One.
2014;9, e98888.19. Seiff A. Cambodia unravels cause of mystery illness. Lancet. 2012;380:206.
20. Solomon T, Lewthwaite P, Perera D, Cardosa MJ, McMinn P, Ooi MH.
Virology, epidemiology, pathogenesis, and control of enterovirus 71.
Lancet Infect Dis. 2010;10:778–90.
21. Organization WH. A Guide to Clinical Management and Public Health
Response for Hand, Foot and Mouth Disease (HFMD). 2009.
22. Zeng M, Li YF, Wang XH, Lu GP, Shen HG, Yu H, et al. Epidemiology of
hand, foot, and mouth disease in children in Shanghai 2007–2010.
Epidemiol Infect. 2012;140:1122–30.
23. Xu Z, Shen H, Wang Z, Altmeyer R, Xia A, Mao S, et al. The population-based
health effect of hand, foot and mouth disease in children in Shanghai.
Pediatr Infect Dis J. 2014;33:448–52.
24. Zhang Q, Macdonald NE, Smith JC, Cai K, Yu H, Li H, et al. Severe
enterovirus type 71 nervous system infections in children in the shanghai
region of china: clinical manifestations and implications for prevention and
care. Pediatr Infect Dis J. 2014;33:482–7.
25. Singh S, Poh CL, Chow VT. Complete sequence analyses of enterovirus 71
strains from fatal and non-fatal cases of the hand, foot and mouth disease
outbreak in Singapore (2000). Microbiol Immunol. 2002;46:801–8.
26. Shih SR, Ho MS, Lin KH, Wu SL, Chen YT, Wu CN, et al. Genetic analysis of
enterovirus 71 isolated from fatal and non-fatal cases of hand, foot and
mouth disease during an epidemic in Taiwan, 1998. Virus Res.
2000;68:127–36.
27. Kung SH, Wang SF, Huang CW, Hsu CC, Liu HF, Yang JY. Genetic and
antigenic analyses of enterovirus 71 isolates in Taiwan during
1998–2005. Clin Microbiol Infect. 2007;13:782–7.
28. Huang SW, Hsu YW, Smith DJ, Kiang D, Tsai HP, Lin KH, et al. Reemergence
of enterovirus 71 in 2008 in taiwan: dynamics of genetic and antigenic
evolution from 1998 to 2008. J Clin Microbiol. 2009;47:3653–62.
29. Cordey S, Petty TJ, Schibler M, Martinez Y, Gerlach D, van Belle S, et al.
Identification of site-specific adaptations conferring increased neural cell
tropism during human enterovirus 71 infection. PLoS Pathog.
2012;8, e1002826.
30. Kiener TK, Jia Q, Meng T, Chow VT, Kwang J. A novel universal neutralizing
monoclonal antibody against enterovirus 71 that targets the highly
conserved “knob” region of VP3 protein. PLoS Negl Trop Dis. 2014;8, e2895.
31. Wu CY, Wang HC, Wang KT, Weng SC, Chang WH, Shih DY, et al.
Neutralization of five subgenotypes of Enterovirus 71 by Taiwanese human
plasma and Taiwanese plasma derived intravenous immunoglobulin.
Biologicals. 2013;41:154–7.
32. Ooi MH, Wong SC, Podin Y, Akin W, del Sel S, Mohan A, et al. Human
enterovirus 71 disease in Sarawak, Malaysia: a prospective clinical,
virological, and molecular epidemiological study. Clin Infect Dis.
2007;44:646–56.
33. Cao RY, Han JF, Jiang T, Tian X, Yu M, Deng YQ, et al. In vitro and in vivo
characterization of a new enterovirus type 71-specific human intravenous
immunoglobulin manufactured from selected plasma donors. J Clin Virol.
2011;51:246–9.
34. Wang SM, Lei HY, Huang MC, Su LY, Lin HC, Yu CK, et al. Modulation of
cytokine production by intravenous immunoglobulin in patients with
enterovirus 71-associated brainstem encephalitis. J Clin Virol. 2006;37:47–52.
35. Perez-Velez CM, Anderson MS, Robinson CC, McFarland EJ, Nix WA,
Pallansch MA, et al. Outbreak of neurologic enterovirus type 71 disease:
a diagnostic challenge. Clin Infect Dis. 2007;45:950–7.
36. Wang JR, Tsai HP, Chen PF, Lai YJ, Yan JJ, Kiang D, et al. An outbreak of
enterovirus 71 infection in Taiwan, 1998. II. Laboratory diagnosis and
genetic analysis. J Clin Virol. 2000;17:91–9.
37. Ooi MH, Wong SC, Lewthwaite P, Cardosa MJ, Solomon T. Clinical features,
diagnosis, and management of enterovirus 71. Lancet Neurol.
2010;9:1097–105.
38. Wang Y, Zhu Q, Zeng M, Altmeyer R, Zou G. Complete genome sequence
of a human enterovirus 71 strain isolated from a fatal case in Shanghai,
China, in 2012. Genome Announc. 2014;2:e00457–14.
39. Zeng M, El Khatib NF, Tu S, Ren P, Xu S, Zhu Q, et al. Seroepidemiology of
Enterovirus 71 infection prior to the 2011 season in children in Shanghai.
J Clin Virol. 2012;53:285–9.
